A5075316902- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Cardiovascular Effects of Exercise
- Cardiovascular Syncope and Autonomic Disorders
- Heart Failure Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- ECG Monitoring and Analysis
- Cardiomyopathy and Myosin Studies
- Cardiac Arrest and Resuscitation
- Cardiac Valve Diseases and Treatments
- Acute Myocardial Infarction Research
- Cardiac Structural Anomalies and Repair
- Healthcare Technology and Patient Monitoring
- Viral Infections and Immunology Research
- Mechanical Circulatory Support Devices
- Cardiovascular and exercise physiology
- Cardiovascular Disease and Adiposity
- Venous Thromboembolism Diagnosis and Management
- Architecture and Computational Design
- Cardiac Health and Mental Health
- Heart Rate Variability and Autonomic Control
Heart Rhythm Society
2022-2025
Midwest Fertility Specialists
2024
University of California, San Diego
2018-2023
Regional Medical Center
2023
UC San Diego Health System
2020-2023
University of California San Diego Medical Center
2023
Yale University
2022
Yale New Haven Hospital
2022
La Jolla Alcohol Research
2021-2022
University of Pittsburgh Medical Center
2020
Left atrial appendage occlusion (LAAO) has emerged as an alternative to anticoagulation for select patients with fibrillation; however, women have been underrepresented in clinical trials of LAAO, and sex-specific subanalyses are limited.To evaluate the sex differences baseline characteristics undergoing LAAO implant in-hospital outcomes after implant.A total 49 357 National Cardiovascular Data Registry Watchman device between January 1, 2016, June 30, 2019, were included this study.Female...
The comparative real-world outcomes of older patients with atrial fibrillation (AF) treated anticoagulation compared left appendage occlusion (LAAO) may be different from those in clinical trials because differences strategies and patient demographics, including a greater proportion women. We sought to compare between AF LAAO by sex.Using Medicare claims data 2015 2019, we identified LAAO-eligible beneficiaries divided them into sex subgroups. Patients receiving were matched 1:1 alone...
Inpatient initiation of sotalol is recommended owing to its proarrhythmic effects.The DASH-AF (Feasibility and Safety Intravenous Sotalol Administered as a Loading Dose Initiate Oral Therapy in Adult Patients With Atrial Fibrillation) trial evaluates the safety feasibility intravenous (IV) sotalol, achieving steady state with maximum QTc prolongation within 6 hours instead traditional 5-dose inpatient oral (PO) titration.DASH-AF prospective, nonrandomized, multicenter, open-label consisting...